RAQUEL TORRES: Open Payments
NPI 1225404171 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$106 in 5 payments from 4 companies in 2025. Trend: 2023 $243 · 2024 $129 · 2025 $106
Food & beverage: $106
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| PFIZER INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: BREZTRI, PAXLOVID, Kerendia, Ozempic, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
